NCT02069041 - A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | Biotech Hunter

Enrollment

8

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Carcinoma, Hepatocellular

Interventions

BIOLOGICAL

Ramucirumab

Administered IV.

DRUG

FOLFOX4

Administered IV.

Trial Locations (3)

10048

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taipei

33305

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Taoyuan

70403

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tainan City